EC-234

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEC-234
Drug Alias NameEC-234
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsIschemiaReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomedica Management Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomedica Management Co
Active IndicationsN/A
Inactive IndicationsIschemiaReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A